These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5453784)

  • 21. [Effect of heparin on blood platelet aggregation and thrombus formation under the influence of a continuous electrical current].
    Mishchenko VI
    Fiziol Zh SSSR Im I M Sechenova; 1972 Nov; 58(11):1744-8. PubMed ID: 4645633
    [No Abstract]   [Full Text] [Related]  

  • 22. Passage of extravascular tracers into canine jugular veins and carotid arteries.
    Stewart GJ; Stewart DD; Philbin JF; Stern HS
    J Lab Clin Med; 1980 Aug; 96(2):285-98. PubMed ID: 7400663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of the action of heparin on thrombocytes].
    Gromnatskiĭ NI
    Vrach Delo; 1969 Mar; 3():90-2. PubMed ID: 5369667
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants].
    Merkulov MF; Lakin KM; Fel'dbaum VA; Efimov VS
    Farmakol Toksikol; 1968; 31(6):706-9. PubMed ID: 5713582
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 26. [Heparin: its mechanism of action and use in cardiology].
    Serneri GG; Rostagno C
    G Ital Cardiol; 1990 Jul; 20(7):670-4. PubMed ID: 2245907
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mechanism of inhibition of blood coagulation (author's transl)].
    Kurachi K
    Tanpakushitsu Kakusan Koso; 1980 Dec; 25(13):1031-40. PubMed ID: 7025099
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits.
    Van Ryn-McKenna J; Merk H; Müller TH; Buchanan MR; Eisert WG
    Thromb Haemost; 1993 Mar; 69(3):227-30. PubMed ID: 8470045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of heparin in the reflex reactions of blood coagulation].
    Kudriashov BA; Kalishevskaia TM; Kovaleva TN; Morozova GA
    Dokl Akad Nauk SSSR; 1969 Feb; 184(5):1239-42. PubMed ID: 5398177
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of releasing heparin from the heparinized hydrophilic polymer (HRSD) on the process of thrombus formation.
    Mori Y; Nagaoka S; Masubuchi Y; Itoga M; Tanzawa H; Kikuchi T; Yamada Y; Yonaha T; Watanabe H; Idezuki Y
    Trans Am Soc Artif Intern Organs; 1978; 24():736-45. PubMed ID: 716090
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism and anticoagulant effect of 51Cr-labelled heparin.
    Alánt O; Varga L; Antoni F; Karácsonyi S; Faller J
    Acta Physiol Acad Sci Hung; 1973; 43(3):261-7. PubMed ID: 4790805
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of heparin in intrinsic blood coagulation.
    Pitlick FA; Lundblad RL; Davie EW
    J Biomed Mater Res; 1969 Mar; 3(1):95-106. PubMed ID: 5784970
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interaction of heparin and thrombocytes (a review of the Soviet and foreign literature)].
    Traskunova NV; Rokhmistrova VD
    Vestn Khir Im I I Grek; 1980 Apr; 124(4):142-6. PubMed ID: 6992400
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recording the volumetric cerebral circulation and its modification by morpholynmethyltetracycline].
    Grinberg GE
    Antibiotiki; 1966 Jan; 11(1):74-7. PubMed ID: 5973449
    [No Abstract]   [Full Text] [Related]  

  • 35. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
    Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of biological activities and chemical analyses for various heparin preparations.
    Jaques LB; Kavanagh L; Lavallée A
    Arzneimittelforschung; 1967 Jun; 17(6):774-8. PubMed ID: 4234593
    [No Abstract]   [Full Text] [Related]  

  • 39. Heparin-coated cardiopulmonary bypass circuit for use during lung transplantation.
    Gu YJ; van Oeveren W; Boonstra PW; de Boer WJ; Ebels T; Prop J
    J Heart Lung Transplant; 1995; 14(3):605-6. PubMed ID: 7503919
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.